Description:

ODM derived from http://clinicaltrials.gov/show/NCT00522834

Link:

http://clinicaltrials.gov/show/NCT00522834

Keywords:
Versions (2) ▾
  1. 12/10/13
  2. 4/14/14
Uploaded on:

April 14, 2014

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00522834 Melanoma

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age at least 18 Years
Histologically confirmed metastatic (Stage IV) melanoma of cutaneous origin
ECOG performance status finding <=2
Measurable disease according to modified RECIST
Life expectancy >12 weeks
LDH <= 2.0 x ULN
Clinical lab values within protocol parameters.
At least 18 years old and able and willing to provide informed consent to participate
Exclusion Criteria
Previous cytotoxic chemotherapy treatment for melanoma
Received more than one regimen of immunotherapy, kinase inhibitor, biologic therapy, vaccine or investigational non-chemotherapeutic treatment for melanoma.
Presence of brain metastases
Presence or history (<= 5 years) of a second malignancy other than nonmelanoma skin cancer or cervical carcinoma in situ
Female subjects who are pregnant or nursing